According to Taro Pharmaceutical's latest financial reports and stock price the company's current number of shares outstanding is 37,584,891. At the end of 2022 the company had 37,584,891 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2022 | 37.58 M | |
2021 | 37.58 M | -1.75% |
2020 | 38.25 M | -0.64% |
2019 | 38.5 M | -1.12% |
2018 | 38.93 M | -2.85% |
2017 | 40.07 M | -2.15% |
2016 | 40.96 M | -4.37% |
2015 | 42.83 M | |
2014 | 42.83 M | -4.18% |
2013 | 44.7 M | -0.06% |
2012 | 44.72 M | 0.56% |
2011 | 44.47 M | 12.61% |
2010 | 39.49 M | 0.65% |
2009 | 39.24 M | 0.14% |
2008 | 39.18 M | |
2005 | 29.27 M | 0.72% |
2004 | 29.06 M | 0.58% |
2003 | 28.9 M | 0.85% |
2002 | 28.65 M | 31% |
2001 | 21.87 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 2,634,300,000 | 6,908.93% | ๐บ๐ธ USA |
![]() Novartis NVS | 2,110,000,000 | 5,513.96% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | 5,634,000,000 | 14,890.07% | ๐บ๐ธ USA |
![]() Merck MRK | 2,536,000,000 | 6,647.39% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | 2,022,000,000 | 5,279.82% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | 1,111,000,000 | 2,855.98% | ๐ฎ๐ฑ Israel |